Stellar Pharmaceuticals Acquires the Exclusive Rights to Collatamp ...
News | 21 June 2012
Stellar Pharmaceuticals Inc. Scott Langille CFO 519-434-1540.
Click on the link to read the full article at Healthcare Global (press release)
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
